Pros | 5Y returns in the top 25% of the category. Lower expense ratio. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 3Y returns in the bottom 25% of the category. |
INDMoney rank | 5/8 | 6/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 7 Years | 12 Years | ||
Fund Size | 2812 Cr | 8459 Cr | ||
Min Investment | SIP ₹99 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.47% | 0.91% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 35 | 40 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (13.06%) Divi's Laboratories Ltd (8.56%) Glenmark Pharmaceuticals Ltd (6.51%) Apollo Hospitals Enterprise Ltd (5.95%) Cipla Ltd (5.54%) | Sun Pharmaceuticals Industries Ltd (13.55%) Lupin Ltd (7.59%) Divi's Laboratories Ltd (6.9%) Cipla Ltd (6.33%) Dr Reddy's Laboratories Ltd (5.83%) | ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors | Health (98.89%) Basic Materials (1.11%) | Health (100%) | ||
Equity % | 99.45% | 99.45% | ||
Debt % | - | - | ||
P/E | 39.45 | 35.82 | ||
P/B | 5.48 | 5.53 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.44% | -1.55% | ||
3-Month Return | -2.97% | -2.39% | ||
6-Month Return | 4.15% | 2.05% | ||
1-Year Return | 0.43% | -0.55% | ||
3-Year Return | 23.26% | 22.71% | ||
5-Year Return | 17.15% | 16.42% |
Sharpe | 0.92 | 0.98 | ||
Alpha | -1.37 | -0.21 | ||
Beta | 1 | 0.91 | ||
Standard Deviation | 16.46 | 15.24 | ||
Information Ratio | -0.61 | -0.48 |
Description | Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Vrijesh Kasera | Sailesh Raj Bhan,Divya Sharma,Kinjal Desai,Lokesh Maru |